Wonder if we close the gap or not?
3 year EBIT CGAR is 12.2 percent. Last year was an anomaly boosted by govt and single drug.
Anywhere between 5-10 percent is good. I reckon it will be closer to high single digits unless new expensive drug gets on the PBS.
big question marks ??????????, page-85
-
- There are more pages in this discussion • 56 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
